Collectively, these findings emphasize the unidirectional influence of the ERK pathway on MMP9 as a downstream target, providing insights into potential therapeutic strategies for mitigating CRC invasion and metastasis. The gene discussed is MMP9; the disease is colorectal carcinoma.